A man living with advanced liver cancer has seen his tumour shrink by over half as “exciting” new clinical trials are ...

Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

A groundbreaking cancer study led by Professor Tom Bird from the Cancer Research UK Scotland Institute has discovered a drug ...

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

A new approach combining immunotherapy, radiation, and surgery enabled successful liver cancer removal in a high-risk patient ...